Dr. Tasha Latrice Young, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 4304 Arabella Ct, Upper Marlboro, MD 20772 Phone: 703-298-4064 Fax: 571-291-6135 |
Dr. Khaled Attia Madi, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1221 Mercantile Ln, Upper Marlboro, MD 20774 Phone: 301-618-5500 |
De La Sole Podiatric Medical Services Llc Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 10507 Observatory Pl, Upper Marlboro, MD 20772 Phone: 404-606-7449 |
Dr. Ademuyiwa Adekola Adetunji, DPM Podiatrist - Primary Podiatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 1450 Mercantile Ln, Ste 151, Upper Marlboro, MD 20774 Phone: 301-386-5453 Fax: 301-386-5396 |
Ade Adetunji Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 1450 Mercantile Ln, Upper Marlboro, MD 20774 Phone: 301-386-5453 Fax: 301-386-5396 |
News Archive
Researchers at Jefferson Medical College have uncovered a novel pattern of gene expression in the stem cell-rich bottom of tiny "crypts" in the tissue lining the colon. By identifying these patterns, the scientists hope to be able to identify mechanisms through which stem cells contribute to the development of colon cancer.
The Food and Drug Administration (FDA) has approved Zyrtec-D (cetirizine HCl 5 mg and pseudoephedrine HCl 120 mg), an allergy drug, for nonprescription use in adults and children 12 years of age and older. This drug combines an antihistamine with a nasal decongestant.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its drug candidate, SPX-106, achieved statistically significant reductions in triglycerides and cholesterol when administered in combination with D-tagatose for nine weeks to genetically engineered mice prone to dyslipidemia.
Results of a European study in this week's issue of THE LANCET suggest that delaying delivery by a few days is as effective as immediate delivery for babies who have experienced fetal trauma. The study also showed that fetuses delivered without delay at 30 weeks or younger had an increased risk of infant disability compared with delayed delivery.
New research, led by the University of Southampton, has demonstrated that a nanoscale device, called a memristor, could be the 'missing link' in the development of implants that use electrical signals from the brain to help treat medical conditions.
› Verified 9 days ago